TP-122A

AXP000232.1 · Phage therapy

Platform
phage cocktail (non-engineered)
Originator
Technophage
Sponsor
Technophage

Names

NameTypeSource
TP-122Apreferred name, codecurator, ctgov
TP-122codectgov

Virus

Role
Phage
Family
Caudoviricetes
Virus
Pseudomonas aeruginosa bacteriophage
Replication
replicating
Source
evidence

Approvals

No regulatory approval recorded.

Clinical trials (1)

TrialTitleStatusPhaseStartPrimary completionEnrolmentConditions
NCT06370598Phase 1/2a to Assess the Safety and Tolerability of TP-122A for the Treatment of Ventilator-Associated PneumoniaUnknownPhase 1/22024-092025-0515Pneumonia, Ventilator-Associated

Recent changes

No changes recorded in its trials yet.

Notes

Anti-Pseudomonas aeruginosa phage product for ventilator-associated pneumonia; the registration calls it the component of the TP-122 cocktail and tests TP-122A itself (phase 1/2a NCT06370598). Separate program from TP-102, which is a different cocktail for a different indication.

How to cite

TP-122A (AXP000232.1). The Abstractinator program registry, release 2026-11-17+2c46e992acfc. https://abstractinator.me/registry/AXP000232.html

Something wrong or missing? Suggest a correction (a GitHub issue; please link your evidence). Entry created 2026-11-11, updated 2026-11-11.